Sonnet Biotherapeutics Holdings Inc.

16/08/2021 | Press release | Archived content

Correspondence (SEC Filing - CORRESP)

August 16, 2021

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Sonnet BioTherapeutics Holdings, Inc. (the 'Company')
Registration Statement on Form S-1 (File No. 333-258092)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the 'Registration Statement') be declared effective by the Securities and Exchange Commission at 4:30 p.m., Eastern Time, on August 17, 2021, or as soon as practicable thereafter.

Please call Alexander E. Dinur of Lowenstein Sandler LLP at 973-422-6732 to confirm the effectiveness of the Registration Statement or with any questions.

Very truly yours,
SONNET BIOTHERAPEUTICS HOLDINGS, INC.
By: /s/ Pankaj Mohan
Name: Pankaj Mohan
Title: Chief Executive Officer